Pacer Advisors, Inc. Beam Therapeutics Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$21.22 - $32.66 $4,116 - $6,336	-194 Reduced 17.11%	940 $22,000
Q1 2024 May 10, 2024	BUY	$23.46 - $45.07 $26,603 - $51,109	1,134 New	1,134 $37,000
Q2 2021 Jul 21, 2021	SELL	$64.12 - $128.71 $50,718 - $101,809	-791 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$71.28 - $120.75 $52,889 - $89,596	-742 Reduced 48.4%	791 $63,000
Q4 2020 Jan 20, 2021	BUY	$22.24 - $95.63 $34,093 - $146,600	1,533 New	1,533 $125,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.